Pleiotropic Effect of Lipoprotein-Apheresis on the Soluble Form of Activated Leukocyte Cell Adhesion Molecule (sALCAM) in Familial Hypercholesterolaemia

Exp Clin Endocrinol Diabetes. 2019 May;127(5):276-280. doi: 10.1055/a-0630-0232. Epub 2018 Jun 11.

Abstract

Atherosclerosis is an inflammatory disorder in which several converging immune responses modulate and induce lipid accumulation in macrophages. Activated leukocyte cell adhesion molecule (ALCAM) has been described as a structural homologue of HDL-receptor and functions as a pattern recognition receptor (PRR), while its soluble form sALCAM is involved in ALCAM-dependent and -independent immune mechanisms. The aim of this study was to investigate the effect of aggressive removal of low density lipoprotein-cholesterol (LDL-C) and lipoprotein(a) (Lp [a]) by lipoprotein-apheresis (LA) on sALCAM and blood viscosity as well as to evaluate its association with lipoproteins and serum markers of inflammation.

MeSH terms

  • Adult
  • Aged
  • Antigens, CD / blood*
  • Atherosclerosis / blood*
  • Atherosclerosis / therapy*
  • Blood Component Removal / methods*
  • Cell Adhesion Molecules, Neuronal / blood*
  • Cholesterol, LDL / blood*
  • Female
  • Fetal Proteins / blood*
  • Humans
  • Hypercholesterolemia / blood*
  • Hypercholesterolemia / genetics
  • Hypercholesterolemia / therapy*
  • Inflammation / blood*
  • Lipoprotein(a) / blood*
  • Male
  • Middle Aged
  • Receptors, Pattern Recognition / blood*
  • Treatment Outcome

Substances

  • ALCAM protein, human
  • Antigens, CD
  • Cell Adhesion Molecules, Neuronal
  • Cholesterol, LDL
  • Fetal Proteins
  • Lipoprotein(a)
  • Receptors, Pattern Recognition